Published in J Lipid Res on August 01, 1992
Forms of lipoprotein lipase in rat tissues: in adipose tissue the proportion of inactive lipase increases on fasting. Biochem J (1996) 1.95
Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. J Clin Invest (2005) 1.49
Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo. Proc Natl Acad Sci U S A (1998) 1.31
Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy. Hum Gene Ther (2014) 1.19
A molecular biology-based approach to resolve the subunit orientation of lipoprotein lipase. Proc Natl Acad Sci U S A (1997) 1.11
Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1. Proc Natl Acad Sci U S A (2011) 1.09
Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues. J Clin Invest (2001) 1.08
Deletion of GPIHBP1 causing severe chylomicronemia. J Inherit Metab Dis (2011) 1.06
Angiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formation. J Biol Chem (2013) 1.03
Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am J Pathol (1994) 1.00
A mutation in the lipoprotein lipase gene is the molecular basis of chylomicronemia in a colony of domestic cats. J Clin Invest (1996) 0.96
GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding. Circ Res (2014) 0.96
Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain. J Biol Chem (2014) 0.93
Assembly of lipoprotein lipase in perfused guinea-pig hearts. Biochem J (1993) 0.86
Overexpression of Rad in muscle worsens diet-induced insulin resistance and glucose intolerance and lowers plasma triglyceride level. Proc Natl Acad Sci U S A (2006) 0.84
Severity of diabetes governs vascular lipoprotein lipase by affecting enzyme dimerization and disassembly. Diabetes (2011) 0.83
Two cases with transient lipoprotein lipase (LPL) activity impairment: evidence for the possible involvement of an LPL inhibitor. Eur J Pediatr (2003) 0.81
Post-transcriptional mechanisms are responsible for the reduction in lipoprotein lipase activity in cardiomyocytes from diabetic rat hearts. Biochem J (1995) 0.78
Equivalent binding of wild-type lipoprotein lipase (LPL) and S447X-LPL to GPIHBP1, the endothelial cell LPL transporter. Biochim Biophys Acta (2014) 0.78
A new monoclonal antibody, 4-1a, that binds to the amino terminus of human lipoprotein lipase. Biochim Biophys Acta (2014) 0.78
Effect of long-term treatment of 3T3-L1 adipocytes with chlorate on the synthesis, glycosylation, intracellular transport and secretion of lipoprotein lipase. Biochem J (1998) 0.77
Atypical features of Thermus thermophilus succinate:quinone reductase. PLoS One (2013) 0.77
Lipoprotein lipase activity in rat cardiomyocytes is stimulated by insulin and dexamethasone. Biochem J (1997) 0.77
Brefeldin A enables synthesis of active lipoprotein lipase in cld/cld and castanospermine-treated mouse brown adipocytes via translocation of Golgi components to endoplasmic reticulum. Biochem J (1996) 0.77
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia (2003) 5.91
Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care (2000) 4.64
Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab (1976) 2.39
Lowering of pHi inhibits Ca2+-activated K+ channels in pancreatic B-cells. Nature (1984) 2.19
Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis (1989) 2.14
Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes (1990) 2.00
Ophthalmoscopy versus fundus photographs for detecting and grading diabetic retinopathy. Invest Ophthalmol Vis Sci (1992) 1.97
Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study. Circulation (2000) 1.76
Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis (1984) 1.73
Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance. Diabetes (1987) 1.67
Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes (1987) 1.61
Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects. AIDS (2000) 1.60
Rationale of the diet-heart statement of the American Heart Association. Report of the Nutrition Committee. Circulation (1993) 1.58
Transcriptional activation of the lipoprotein lipase and apolipoprotein E genes accompanies differentiation in some human macrophage-like cell lines. Biochemistry (1988) 1.52
Evidence for intergenic complementation in hybrid cells derived from two human diploid strains each carrying an X-linked mutation. Proc Natl Acad Sci U S A (1969) 1.48
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res (1983) 1.46
Urinary xanthine stones--a rare complications of allopurinol therapy. N Engl J Med (1969) 1.45
Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr (2001) 1.45
Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men. Diabetes Care (1995) 1.44
Abnormal body fat distribution detected by computed tomography in diabetic men. Invest Radiol (1986) 1.44
Development of lipoprotein lipase in cultured 3T3-L1 cells. Biochem Biophys Res Commun (1977) 1.43
Hypoxanthine-guanine phosphoribosyltransferase deficiency: activity in normal, mutant, and heterozygote-cultured human skin fibroblasts. Proc Natl Acad Sci U S A (1970) 1.42
Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity. J Clin Invest (1975) 1.42
A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency. Proc Natl Acad Sci U S A (1989) 1.41
Body fat distribution and dyslipidemia. Am J Med (1995) 1.40
Human adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma enzyme. Am J Physiol (1985) 1.38
Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest (1973) 1.38
Sweet tooth reconsidered: taste responsiveness in human obesity. Physiol Behav (1985) 1.37
Single vertical spin density gradient ultracentrifugation. Methods Enzymol (1986) 1.36
Biochemical diagnosis of an X-linked disease in utero. Lancet (1968) 1.34
Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo. Proc Natl Acad Sci U S A (1998) 1.31
Prevalence of overweight and central adiposity is associated with percentage of indigenous ancestry among native Hawaiians. Int J Obes Relat Metab Disord (1999) 1.30
Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes. Diabetes Care (1989) 1.29
Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes (1995) 1.29
Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans. Ann Hum Genet (2004) 1.27
Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes (1990) 1.27
Effect of a fat free, high carbohydrate diet on diabetic subjects with fasting hyperglycemia. Diabetes (1974) 1.27
Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care (1999) 1.26
The visceral adiposity syndrome in Japanese-American men. Obes Res (1994) 1.26
Fatness, fat distribution, and glucose tolerance in second-generation Japanese-American (Nisei) men. Am J Clin Nutr (1989) 1.26
Lipoprotein lipase secretion by human monocyte-derived macrophages. J Clin Invest (1982) 1.26
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia. Eur J Clin Invest (1980) 1.25
Improved glucose tolerance with high carbohydrate feeding in mild diabetes. N Engl J Med (1971) 1.25
Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb (1993) 1.24
Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial. Diabetes (1995) 1.24
Increase of adipose tissue lipoprotein lipase activity with weight loss. J Clin Invest (1981) 1.23
Cardiovascular complications in renal failure. J Am Soc Nephrol (1991) 1.21
Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism (1976) 1.21
Acquired hyperlipidemia (secondary dyslipoproteinemias). Endocrinol Metab Clin North Am (1990) 1.20
Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes. J Lipid Res (1992) 1.20
Standard definitions of overweight and central adiposity for determining diabetes risk in Japanese Americans. Am J Clin Nutr (2001) 1.18
Nutrition principles for the management of diabetes and related complications. Diabetes Care (1994) 1.15
Hypoxanthine-guanine phosphoribosyltransferase deficiency: chemical agents selective for mutant or normal cultured fibroblasts in mixed and heterozygote cultures. Proc Natl Acad Sci U S A (1971) 1.15
Free fatty acids in the pancreatitic arthritis syndrome. Arthritis Rheum (1983) 1.14
Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes. Diabetes (1979) 1.14
Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J Lipid Res (1993) 1.14
Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion. Eur J Clin Invest (1981) 1.14
Congenital generalized lipodystrophy accompanied by cystic angiomatosis. Ann Intern Med (1968) 1.13
Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase. J Clin Invest (1977) 1.12
Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis (1990) 1.12
Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese-Americans. Diabetologia (2007) 1.12
Weight loss leads to a marked decrease in nonresting energy expenditure in ambulatory human subjects. Metabolism (1988) 1.10
Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol (1998) 1.09
Chylomicronemia syndrome. Adv Intern Med (1992) 1.09
Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb (1992) 1.09
Detailed characterization of the binding site of the lipoprotein lipase-specific monoclonal antibody 5D2. J Lipid Res (1998) 1.09
Control of clofibrate toxicity in uremic hypertriglyceridemia. Clin Pharmacol Ther (1977) 1.08
Chylomicronemia syndrome in diabetes mellitus. Diabetes Care (1982) 1.08
Fibroblast monolayer cultures in scintillation counting vials: metabolic and growth experiments using radioisotopes and a microfluoremetric DNA assay. In Vitro (1977) 1.08
Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia. Med Clin North Am (1982) 1.07
Mutagenesis in four candidate heparin binding regions (residues 279-282, 291-304, 390-393, and 439-448) and identification of residues affecting heparin binding of human lipoprotein lipase. J Lipid Res (1994) 1.07
Educational attainment and the risk of non-insulin-dependent diabetes or coronary heart disease in Japanese-American men. Ethn Dis (1992) 1.07
Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation (1999) 1.05
Type-III Hyperlipoproteinaemia ("remnant removal disease"). Insight into the pathogenetic mechanism. Lancet (1977) 1.05
Heterogeneity of primary lipoprotein lipase deficiency. Metabolism (1980) 1.05
Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood (1997) 1.05
Human lipoprotein lipase. Analysis of the catalytic triad by site-directed mutagenesis of Ser-132, Asp-156, and His-241. J Biol Chem (1992) 1.04
Relationship between lipoprotein lipase activity and plasma sex steroid level in obese women. J Clin Invest (1988) 1.04
Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res (1983) 1.03
Mossbauer spectroscopic evidence for low-spin iron in dehydrated metmyoglobin. Biochemistry (1966) 1.03
Molecular genetics of apolipoproteins and coronary heart disease. Cold Spring Harb Symp Quant Biol (1986) 1.03
On the mechanism of action of atromid-S on triglyceride transport in man. Trans Assoc Am Physicians (1970) 1.03
Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes (1998) 1.03
High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. J Lipid Res (1994) 1.02
The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity. J Clin Endocrinol Metab (2001) 1.02
Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol (1994) 1.02
A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc Natl Acad Sci U S A (1995) 1.01
Identification of heterozygous genotype for cystinosis in utero by a new pulse-labeling technique: preliminary report. J Pediatr (1970) 1.01
Amino acid substitution (Ile194----Thr) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands. Support for a multicentric origin. J Clin Invest (1991) 1.01
Paraoxonase genotypes, lipoprotein lipase activity, and HDL. Arterioscler Thromb Vasc Biol (1996) 1.01
Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis (1989) 1.01
Substituted deuteroporphyrins. I. Reactions at the periphery of the porphyrin ring. J Org Chem (1966) 1.01
Somatostatin inhibition of insulin and glucagon secretion in rat islet culture: reversal by ionophore A23187. Endocrinology (1976) 1.01
Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men. Int J Obes Relat Metab Disord (2000) 1.00